As broadly acknowledged, accelerated senescence can contribute to AF, manifested by increased SA-β-gal activity and elevated p53, p21, and p16 levels in the atrium of AF individuals under 60 years old, and additionally, SA-β-gal activity and p16 are positively associated with the degree of atrial fibrosis [18]. Here, TP53 is linked to atrial fibrillation.